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сахарный диабет  (39 – 27,1%), ХОБЛ (36- 25,0%), 
заболевания печени и желчевыводящих путей (34 
- 23,6%) и ЖКТ (31- 21,5%).  Алкоголизм  отмечен 
в  4 (2,8%) случаях.  Наряду с этим, причинами 
явились лекарственная резистентность (40,6%), 
кроме  ТБ МЛУ, побочные реакции на противо-
туберкулезные препараты 1 ряда (14,8%) и низкое 
материальное положение (71,4%).
Таким образом, анализ показал, что продление 
интенсивной фазы до  3-4 месяцев  показано для 
пациентов с распространенными процессами, низ-
ким материальным положением и   лекарственной 
резистентностью. Вместе с тем, продление интен-
сивной фазы на 1 месяц  необходимо, так как у 
впервые выявленных больных туберкулезом  ко 
2 месяцу не достигается рекомендуемый  ВОЗом 
показатель  конверсии  мазка (85%). 
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Well known that DOTS strategy of WHO as a main 
and economically the most effective policy to fi ght 
against tuberculosis was implemented countrywide 
in Kazakhstan since 1999.  In 2001 the National 
Programme on TB proposed the “adapted DOTS” 
that suggested the prolongation of the intensive phase 
of chemotherapy for patients with tuberculosis. But, 
despite of decrease in TB incidence and TB mortality, 
epidemiological situation in Kazakhstan remains 
unfavorable yet.  The factors of this are as following: 
the high rate of multidrug resistance (21.3%), increase 
in number of newly detected patients with destructive 
TB forms (38.9%), and in number of patients with 
TB meningitis (30 cases). and miliary tuberculosis 
(45 cases), the high indicator of treatment failure 
among new cases with positive sputum smear (9.7%), 
low indicator of cure among new cases with positive 
sputum smear (68.5%). In connection with this timely 
detection and treatment of new cases, early diagnostics 
of drug resistance are topical for determination of the 
further tactics in management of a patient.
Target of our investigation was to study the 
causes of prolongation of the intensive phase of 
chemotherapy for patients treated under regimens of 
DOTS category 1.
For this, we analyzed 381 disease histories of 
patients treated by DOTS category 1 in the Department 
of Pulmonary TB #3 at the National Center for TB 
Problems over 2006-2007-2008. Out of them the 
intensive phase was prolonged up to 3-4 months   for 
283 (74.3%). Intensive phase was prolonged up to 
3 months in 132 (46.6%) cases, up to 4 months to 
151 (53.4%). Among those men were 154 (54.4%), 
women 129 (45.6%). Distribution by age groups: 137 
patients were in the age 18-29 years old, 67 (23.7%) 
- 30-39 years, 35 (12.7%) - 40-49 years, 44 (15.2%) 
- 50 or older.   Infi ltrative pulmonary TB form was 
diagnosed in 242 patients (85.5%, fi bro-cavernous 
pulmonary TB in 23 (8.1%), disseminated TB form in 
11 (3.9%), caseous pneumonia in 7 (2.5%). Bilateral 
pulmonary TB process was observed in 82 (28.9%), 
unilateral process in 199 (71.1%), at this total lung 
injury occurred in 95 (33.6%), one lobe injury in 102 
(36.0%), injury of one segment in 2 (1.5%).
As a result of investigation performed, we found-
out that the causes of prolongation of the intensive 
phase of treatment were the absence of sputum smear 
conversion (25,2%), expanded lung process (99.2%), 
pulmonary TB with complications (36.4%), advanced 
pulmonary TB cases such as caseous pneumonia, fi bro-
cavernous tuberculosis, disseminated pulmonary TB 
(14.5%), association of TB with TB of other organs 
and systems (1.9%), concomitant diseases  (50.9%), 
mainly diabetes mellitus (39 -27.1%), chronic 
obstructive lung diseases (36-25.0%), hepatic and 
biliary ducts diseases (34-23.6%) and gastrointestinal 
diseases (31-21.5%). Alcoholism was marked in 4 
(2.8%) cases. Along with, drug resistance (40.6%) 
beside MDR TB, adverse reactions to anti-TB drugs 
of the fi rst line (14.8%) and low income also were the 
causes of prolongation. 
Thus, analysis showed that the prolongation of 
the intensive phase up to 3-4 months is indicated for 
patients with expanded TB processes, low income 
and drug resistance. Along with, intensive phase 
prolongation is necessary since the recommended by 
WHO indicator of sputum smear conversion (85%) 
commonly is not obtained by 2nd month of treatment. 
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